This study examines two different forms of a combination medication containing rosuvastatin and ezetimibe, which are drugs used to lower cholesterol levels in the blood. The study compares a film-coated tablet version to a hard capsule version of the same medication. Both forms contain the same amount of active ingredients – 20 mg of rosuvastatin and 10 mg of ezetimibe.
The purpose of the study is to determine if both forms of the medication work similarly in the body. The study involves healthy volunteers who will take a single dose of each form of the medication at different times. The medication will be given by oral administration (taken by mouth) when participants have not eaten (fasting conditions).
During the study, researchers will measure how much of each active ingredient enters the bloodstream and how quickly this happens. This type of study, known as a bioequivalence trial, helps determine if the two different forms of the medication have the same effect in the body. The study uses a crossover design, which means each participant will receive both forms of the medication at different times during the study.
Spain 
